|
|
U.S. Neurosurgical, Inc. - Comparative Business Analysis Snapshot
Business Description
U.S. Neurosurgical, Inc.. The Group's principal activity is to own and operate stereotactic radiosurgery centers, utilizing the Gamma Knife technology. The Gamma Knife is a radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery. It owns and operates two Gamma Knife centers in Kansas City and New York. Its target market is medical centers in major health care catchment areas that have physicians experienced with and dedicated to use gamma knife. The Group operates throughout the United States.
Competitor Analysis
This analysis compares U.S. Neurosurgical, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
